Indeed, Fluge et al. found strong differences when analyzing colon and rectal tumors separately and reported a significant correlation of low EZH2 expression to relapse-free survival only in colon, but not in rectal cancer (Fluge et al. 2009). Here, EZH2 is linked to rectal neoplasm.